Subscribe
Sign In
|
Subscribe Ad-Free
Joshua Lamel
Author Archive
2023
2019
Dec 6, 2023
How a ‘Public Benefit’ Pharma Company Undermines Real Innovation
The U.S. Court of Appeals for the Federal Circuit heard oral arguments this month in a patent dispute between Big Pharma giant United Therapeutics Corporation (UTC) and a small...